Dosing

1 stories · following the connections

Business

VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine

By Nasdaq OMXApr 19, 2018, 12:00 PM UTC